Using convalescent plasma transfusion as adjunctive therapy may not help prevent disease progression among hospitalized coronavirus disease (COVID-19) patients, the Department of Science and Technology (DOST) said Thursday, Dec. 9. (Photo by Rodrigo ARANGUA / AFP / MANILA BULLETIN) Results of the...
Results of the virgin coconut oil (VCO) trial at Philippine General Hospital (PGH) showed that hospitalized coronavirus disease (COVID-19) patients did not significantly benefit from VCO as an adjunct therapy. (MANILA BULLETIN FILE) The results of the VCO clinical trial at the PGH were presented by...
The Department of Science and Technology (DOST) said Sunday, Oct. 17, that the results of the virgin coconut oil (VCO) trial at Philippine General Hospital (PGH) which aims to determine the safety and efficacy of VCO as adjunctive therapy for coronavirus disease (COVID-19) cases may be out by end...